Resource implications of febrile neutropenia in cancer patients. An international collaborative study

Supportive Care in Cancer

Volumn 7, Issue 5, 1999, Pages 343-346

  Harbarth, Stephan ^a   Beeler, Iris ^c   Viot, Michele ^b   Szucs, Thomas D ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antimicrobials; Febrile neutropenia; Resource utilization

Indexed keywords

ANTIINFECTIVE AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD DISEASE; BREAST CANCER; CANCER PATIENT; CLINICAL PRACTICE; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADULT; AUSTRALIA; BRAZIL; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; FEVER OF UNKNOWN ORIGIN; HEALTH RESOURCES; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 0032795006     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050273     Document Type: Article

References (8)

1. Talcott JA, Finberg R, Mayer RJ, Goldman L (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 148:2561-2568
2. Nucci M, Spector N, Bueno AP, Solza C, Pereomanis T, Bacha PC, et al (1997) Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer. Clin Infect Dis 24:575-579
3. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al (1997) 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 25:551-573
4. Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, et al (1997) Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 336:1781-1787
5. Klastersky J (1998) Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 41: [Suppl D]:13-24
6. Klastersky J (1998) Current attitudes for therapy of febrile neutropenia with consideration to cost-effectiveness. Curr Opin Oncol 10:284-290
7. Lyman GH, Kuderer NM, Balducci L (1998) Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia. Curr Opin Oncol 10:291-296
8. Torfs K, Pocceschi S (1996) A retrospective study of resource utilisation in the treatment of advanced colorectal cancer in Europe. Eur J Cancer [A] 32 [Suppl 5]:S28-31